Empowerment of mosque communities to increase body immune with aroma therapy robots
DOI:
https://doi.org/10.59247/jppmi.v1i4.16Keywords:
COVID-19, Therapy, Mosque, Aromatherapy, ImmunityAbstract
Treatment of patients suffering from infection with the novel corona virus by means of therapy because there is no one drug to cure patients affected by Covid-19. Patients with COVID-19 are undergoing therapy to boost their immune system. One of the therapies to increase the body's immunity is by using aromatherapy. This community empowerment program applies aromatherapy robots to increase the immunity of the congregation who are carrying out worship activities at the mosque. The purpose of this community empowerment is to create and implement an aromatherapy robot that has an aromatherapy liquid level indicator and can refill aromatherapy with liquids from plants. The method of implementing the community empowerment program is as follows. The robot was made by UMY community service staff consisting of nine people who are experts in their respective fields, chaired by Dr., Ir., Iswanto., S.T., M.Eng., IPM who is an expert in robotics. There are members from the University of Muhammadiyah Yogyakarta, University of UIN Sunan Kalijaga Yogyakarta, Ahmad Dahlan University and the University of Tlaxcala, Mexico. There are five members from the University of Muhammadiyah Yogyakarta, namely Dr., Adhianty Nurjanah, S.Sos., M.Sc. expert in disaster communication, Dr. Ir. Gatot Supangkat who is an expert in the field of plants and Dhiya Uddin Rijalussalam., S.T who is an expert in the field of robot assembly. Members from outside UMY are Nia Maharani Raharja., S.T., M.Eng. from the University of UIN Sunan Kalijaga Yogyakarta, an expert in instrumentation, Alfian Maarif., S.T., M.Eng. from Ahmad Dahlan University, an expert in control and Professor Ph.D. Carlos Sánchez-López is an expert in the field of autonomous robots from the University of Tlaxcala, Mexico. With this aromatherapy robot, mosque congregations can increase their immunity by inhaling the aromatherapy in the robot.
References
H. Ho, Y. Chen, and C. Yen, “Different impacts of COVID-19-related information sources on public worry: An online survey through social media,” Internet Interv., vol. 22, no. July, p. 100350, Dec. 2020, doi: 10.1016/j.invent.2020.100350.
N. Rollins et al., “A public health approach for deciding policy on infant feeding and mother–infant contact in the context of COVID-19,” Lancet Glob. Heal., vol. 9, no. 4, pp. e552–e557, Apr. 2021, doi: 0.1016/S2214-109X(20)30538-6.
V. Bianconi, M. R. Mannarino, P. Bronzo, E. Marini, and M. Pirro, “Time-related changes in sex distribution of COVID-19 incidence proportion in Italy,” Heliyon, vol. 6, no. 10, p. e05304, Oct. 2020, doi: 10.1016/j.heliyon.2020.e05304.
B. Pérez-Gómez et al., “ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19,” J. Clin. Epidemiol., vol. 139, pp. 240–254, Nov. 2021, doi: 10.1016/J.JCLINEPI.2021.06.005.
A. A. Malik, S. M. McFadden, J. Elharake, and S. B. Omer, “Determinants of COVID-19 vaccine acceptance in the US,” EClinicalMedicine, vol. 26, p. 100495, Sep. 2020, doi: 10.1016/j.eclinm.2020.100495.
S. Yegorov et al., “Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: A nation-wide retrospective cohort study,” Lancet Reg. Heal. - Eur., vol. 4, p. 100096, May 2021, doi: 10.1016/j.lanepe.2021.100096.
A. Gbadamosi, L. Oyedele, O. Olawale, and S. Abioye, “Offsite Construction for Emergencies: A focus on Isolation Space Creation (ISC) measures for the COVID-19 pandemic,” Prog. Disaster Sci., vol. 8, p. 100130, Dec. 2020, doi:
M. Montalti et al., “ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance,” eClinicalMedicine, vol. 38, p. 101027, Aug. 2021, doi: 10.1016/J.ECLINM.2021.101027.
Y. Miki, N. Chubachi, F. Imamura, N. Yaegashi, and K. Ito, “Impact of COVID-19 restrictions on the research environment and motivation of researchers in Japan,” Prog. Disaster Sci., vol. 8, p. 100128, Dec. 2020, doi: 10.1016/j.pdisas.2020.100128.
F. S. Taccone et al., “The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium,” Lancet Reg. Heal. - Eur., vol. 2, p. 100019, Mar. 2021, doi: 10.1016/j.lanepe.2020.100019.
T.-K. T. Dinh, L. M. Halasz, E. Ford, and R. Rengan, “Radiation Therapy in King County, Washington During the COVID-19 Pandemic: Balancing Patient Care, Transmission Mitigation, and Resident Training,” Adv. Radiat. Oncol., vol. 5, no. 4, pp. 544–547, Jul. 2020, doi: 10.1016/j.adro.2020.03.007.
T. Wang, Q. Xiang, and J. Bian, “Promising gas therapies for severe COVID-19,” J. Intensive Med., pp. 19–22, May 2021, doi: 10.1016/j.jointm.2021.05.001.
M. Bianco et al., “COVID-19 therapies and their impact on QT interval prolongation: A multicentre retrospective study on 196 patients,” IJC Hear. Vasc., vol. 30, p. 100637, Oct. 2020, doi: 10.1016/j.ijcha.2020.100637.
M. Jeyaraman et al., “Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19,” Heliyon, vol. 7, no. 7, p. e07635, Jul. 2021, doi: 10.1016/j.heliyon.2021.e07635.
E. Adams and A. Y. Mousa, “Achieving a popliteal venous access for renal replacement therapy in critically ill COVID-19 patient in prone position,” J. Vasc. Surg. Cases, Innov. Tech., vol. 6, no. 2, pp. 266–268, Jun. 2020, doi: 10.1016/j.jvscit.2020.04.003.
P. Grivas et al., “Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium,” Ann. Oncol., vol. 32, no. 6, pp. 787–800, Jun. 2021, doi: 10.1016/J.ANNONC.2021.02.024.
M. Taha, A. Sharma, and A. Soubani, “Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19,” Respir. Med. Case Reports, vol. 31, p. 101231, Jan. 2020, doi: 10.1016/J.RMCR.2020.101231.
M. A. Munir, P. A. Tandiabang, T. Setyawati, A. Basry, A. D. Cyio, and N. Rahman, “Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review,” Transfus. Clin. Biol., vol. 28, no. 3, pp. 271–275, Aug. 2021, doi: 10.1016/j.tracli.2021.03.005.
H.-I. Shih, C.-J. Wu, Y.-F. Tu, and C.-Y. Chi, “Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines,” Biomed. J., vol. 43, no. 4, pp. 341–354, Aug. 2020, doi: 10.1016/j.bj.2020.05.021.
W. A. Jones, R. de C. Castro, H. L. Masters, and R. Carrico, “Influenza Management During the COVID-19 Pandemic: A Review of Recent Innovations in Antiviral Therapy and Relevance to Primary Care Practice,” Mayo Clin. Proc. Innov. Qual. Outcomes, vol. 5, no. 6, pp. 974–991, Dec. 2021, doi: 10.1016/J.MAYOCPIQO.2021.07.005.
S. Zimman, M. J. Cura, P. C. Lun, C. M. Echeverría, and L. D. Mazzuoccol, “Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina,” Actas Dermosifiliogr., vol. 111, no. 9, p. 806, Nov. 2020, doi: 10.1016/J.ADENGL.2020.10.010.
N. Giesen et al., “2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy,” Eur. J. Cancer, vol. 147, pp. 154–160, Apr. 2021, doi: 10.1016/j.ejca.2021.01.033.
S. D. M. van Dijk et al., “(Vi)-rushed Into Online Group Schema Therapy Based Day-Treatment for Older Adults by the COVID-19 Outbreak in the Netherlands,” Am. J. Geriatr. Psychiatry, vol. 28, no. 9, pp. 983–988, Sep. 2020, doi: 10.1016/j.jagp.2020.05.028.
S. Saha and S. Kadam, “Convalescent plasma therapy - a silver lining for COVID-19 management?,” Hematol. Transfus. Cell Ther., vol. 43, no. 2, pp. 201–211, Apr. 2021, doi: 10.1016/j.htct.2021.03.004.
G. Miranda-Zazueta et al., “Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic,” Rev. Gastroenterol. México (English Ed., vol. 85, no. 3, pp. 312–320, Jul. 2020, doi: 10.1016/J.RGMXEN.2020.06.002.
D. Kumar et al., “Ventricular fibrillation storm in COVID 19 responding to steroid therapy: A case report,” IHJ Cardiovasc. Case Reports, vol. 5, no. 3, pp. 177–180, Sep. 2021, doi: 10.1016/J.IHJCCR.2021.07.007.
W. R. Geisen et al., “Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy,” IDCases, vol. 22, p. e00962, Jan. 2020, doi: 10.1016/J.IDCR.2020.E00962.
N. Mori, M. Katayama, and S. Nukaga, “Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia,” J. Microbiol. Immunol. Infect., vol. 54, no. 1, pp. 109–112, Feb. 2021, doi: 10.1016/j.jmii.2020.09.003.
E. Freire-Álvarez et al., “COVID-19-associated encephalitis successfully treated with combination therapy,” Clin. Infect. Pract., vol. 7–8, p. 100053, Oct. 2020, doi: 10.1016/j.clinpr.2020.100053.
R. Lima-Morales et al., “Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico,” Int. J. Infect. Dis., vol. 105, pp. 598–605, Apr. 2021, doi: 10.1016/j.ijid.2021.02.014.
M. Morais-Almeida et al., “COVID-19, asthma, and biological therapies: What we need to know,” World Allergy Organ. J., vol. 13, no. 5, p. 100126, May 2020, doi: 10.1016/j.waojou.2020.100126.
W. Takahashi et al., “Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation,” Int. J. Infect. Dis., vol. 102, pp. 529–531, Jan. 2021, doi: 10.1016/j.ijid.2020.10.093.
F. Dastan et al., “Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19,” J. Glob. Antimicrob. Resist., vol. 21, pp. 340–341, Jun. 2020, doi: 10.1016/j.jgar.2020.04.024.
H. Li et al., “Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study,” Int. J. Infect. Dis., vol. 104, pp. 641–648, Mar. 2021, doi: 10.1016/j.ijid.2021.01.055.
S. Jang and J.-Y. Rhee, “Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy,” Int. J. Infect. Dis., vol. 96, pp. 500–502, Jul. 2020, doi: 10.1016/j.ijid.2020.05.072.
J. F. S. D. Lana et al., “Nebulization of glutathione and N-Acetylcysteine as an adjuvant therapy for COVID-19 onset,” Adv. Redox Res., vol. 3, p. 100015, Dec. 2021, doi: 10.1016/j.arres.2021.100015.
P. Samson et al., “Clinical and Radiographic Presentations of COVID-19 Among Patients Receiving Radiation Therapy for Thoracic Malignancies,” Adv. Radiat. Oncol., vol. 5, no. 4, pp. 700–704, Jul. 2020, doi: 10.1016/j.adro.2020.04.020.
J. Drulovic et al., “HUMORAL RESPONSE TO SARS-CoV-2 AND COVID-19 VACCINES IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH IMMUNE RECONSTITUTION THERAPIES,” Mult. Scler. Relat. Disord., vol. 54, p. 103150, Sep. 2021, doi: 10.1016/j.msard.2021.103150.
E. Nasonov and M. Samsonov, “The role of Interleukin 6 inhibitors in therapy of severe COVID-19,” Biomed. Pharmacother., vol. 131, p. 110698, Nov. 2020, doi: 10.1016/j.biopha.2020.110698
N. Bernardini et al., “How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient’s perception: Study on 600 patients on biologic therapy,” J. Infect. Public Health, vol. 14, no. 7, pp. 878–882, Jul. 2021, doi: .1016/j.jiph.2021.03.010.
M. Maghami, M. R. Afazel, I. Azizi-Fini, and M. Maghami, “The effect of aromatherapy with peppermint essential oil on nausea and vomiting after cardiac surgery: A randomized clinical trial,” Complement. Ther. Clin. Pract., vol. 40, p. 101199, Aug. 2020, doi: 10.1016/j.ctcp.2020.101199.
M. Rambod, M. Rakhshan, S. Tohidinik, and M. H. Nikoo, “The effect of lemon inhalation aromatherapy on blood pressure, electrocardiogram changes, and anxiety in acute myocardial infarction patients: A clinical, multi-centered, assessor-blinded trial design,” Complement. Ther. Clin. Pract., vol. 39, p. 101155, May 2020, doi: 10.1016/j.ctcp.2020.101155.
F. Abdollahi and T. Mobadery, “The effect of aromatherapy with bitter orange (Citrus aurantium) extract on anxiety and fatigue in type 2 diabetic patients,” Adv. Integr. Med., vol. 7, no. 1, pp. 3–7, Mar. 2020, doi: 10.1016/j.aimed.2019.01.002.
N. J. Sadgrove, “Southern Africa as a ‘cradle of incense’ in wider African aromatherapy,” Sci. African, vol. 9, p. e00502, Sep. 2020, doi: 10.1016/j.sciaf.2020.e00502.
M. R. Asgari, A. Vafaei-Moghadam, H. Babamohamadi, R. Ghorbani, and R. Esmaeili, “Comparing acupressure with aromatherapy using Citrus aurantium in terms of their effectiveness in sleep quality in patients undergoing percutaneous coronary interventions: A randomized clinical trial,” Complement. Ther. Clin. Pract., vol. 38, p. 101066, Feb. 2020, doi: 10.1016/j.ctcp.2019.101066.
N. Kawabata, A. Hata, and T. Aoki, “Effect of Aromatherapy Massage on Quality of Sleep in the Palliative Care Ward: A Randomized Controlled Trial,” J. Pain Symptom Manage., vol. 59, no. 6, pp. 1165–1171, Jun. 2020, doi: 10.1016/j.jpainsymman.2020.01.003.
A. Khatteli, M. A. Benabderrahim, T. Triki, and F. Guasmi, “Aroma volatiles, phenolic profile and hypoglycaemic activity of Ajuga iva L.,” Food Biosci., vol. 36, p. 100578, Aug. 2020, doi: 10.1016/j.fbio.2020.100578.
R. Goli, M. Arad, M. Mam-Qaderi, and N. Parizad, “Comparing the effects of geranium aromatherapy and music therapy on the anxiety level of patients undergoing inguinal hernia surgery: A clinical trial,” EXPLORE, vol. 18, no. 1, pp. 57–63, Jan. 2022, doi: 10.1016/J.EXPLORE.2020.08.004.
R. Schneider, “Essential oil inhaler (AromaStick®) improves heat tolerance in the Hot Immersion Test (HIT). Results from two randomized, controlled experiments,” J. Therm. Biol., vol. 87, p. 102478, Jan. 2020, doi: 10.1016/j.jtherbio.2019.102478.
R. Shirzadegan, M. Gholami, S. Hasanvand, and A. Beiranvand, “The effects of Citrus aurantium aroma on anxiety and fatigue in patients with acute myocardial infarction: A two-center, randomized, controlled trial,” J. Herb. Med., vol. 21, p. 100326, Jun. 2020, doi: 10.1016/j.hermed.2019.100326.
F. Askarkafi, M. Rayyani, and M. Dehghan, “The Effect of Massage With and Without Aromatic Oil on Delirium After Open-Heart Surgery: A Randomized Controlled Trial,” J. Chiropr. Med., vol. 19, no. 1, pp. 49–57, Mar. 2020, doi: 10.1016/j.jcm.2019.08.001.
N. Sadeghi, A. Azizi, S. Asgari, and Y. Mohammadi, “The effect of inhalation aromatherapy with damask rose essence on pain intensity and anxiety in burned patients: A single-blind randomized clinical trial,” Burns, vol. 46, no. 8, pp. 1933–1941, Dec. 2020, doi: 10.1016/j.burns.2020.05.006.
F. Ghaderi and N. Solhjou, “The effects of lavender aromatherapy on stress and pain perception in children during dental treatment: A randomized clinical trial,” Complement. Ther. Clin. Pract., vol. 40, p. 101182, Aug. 2020, doi: 10.1016/j.ctcp.2020.101182.
K. Ganesan and B. Xu, “Deep frying cooking oils promote the high risk of metastases in the breast-A critical review,” Food Chem. Toxicol., vol. 144, p. 111648, Oct. 2020, doi: 10.1016/j.fct.2020.111648.
A. Abdusalam et al., “Documenting the heritage along the Silk Road: An ethnobotanical study of medicinal teas used in Southern Xinjiang, China,” J. Ethnopharmacol., vol. 260, p. 113012, Oct. 2020, doi: 10.1016/j.jep.2020.113012.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Jurnal Pengabdian dan Pemberdayaan Masyarakat Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
